Not the same as the HERA/BCIRG trials
I think we need to be careful when comparing this trial to HERA and the BCIRG trials on early BC patients since this was a trial on patients with metastatic cancer. As a treatment for stage IV women who have already had anthracyclines it looks like a big step forward.
|